NantKwest Inc.
(NK:NASDAQ
NantKwest is an innovative, clinical-stage immunotherapy company focused on harnessing the power of the innate immune system to treat cancer and virally induced infectious diseases. NantKwest is the leading producer of clinical dose forms of off-the-shelf Natural Killer (NK) cell therapies.
Streetwise Company Fact Sheet
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
